TAK-751S

DB06432InvestigationalSmall molecule

TAK-751S is a synthetic analog of Shiga toxin (Stx) receptor, Gb3, produced by enterohemorrhagic Escherichia coli.

Primary indication
Investigated for use/treatment in pediatric indications and infectious and parasitic disease (unspecified).Curator reviewed
Also known as
Synsorb Pk · Synsorb-Pk
Code names
TAK-751S

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of TAK-751S, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account